What is the market cap of Bristol-Myers Squibb?

The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth. On Oct 12th, 2023 the market cap of Bristol-Myers Squibb was reported to be: As of October 2023 Bristol-Myers Squibb has a market cap of $117.59 Billion.

What does Bristol Myers Squibb do?

The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol Myers Squibb focuses on products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

Are Merck and Bristol Myers Squibb getting a big slice?

Merck (NYSE: MRK) and Bristol Myers Squibb (NYSE: BMY) are both eyeing the same pie, and they're both serious about getting a big slice. It's the market for antibody-drug conjugates (ADCs), an emerging but proven therapeutic modality that should really take off through the rest of the decade after a successful first act.

Is Bristol-Myers Squibb a biopharmaceutical company?

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and hematology.

The World's Leading Crypto Trading Platform

Get my welcome gifts